Clear Blemish Treatment

Product NDC: 68828-129
11-digit product format: 688280129
Labeler code: 68828
Product ID: 68828-129_a8b440d1-7efe-3699-e053-2a95a90a7a48
Type: HUMAN OTC DRUG
Nonproprietary name: Salicylic Acid
Dosage form: GEL
Route: TOPICAL
Labeler: JAFRA COSMETICS INTERNATIONAL
Application: part358H
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-06-19
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 2 g/151mL
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68828-129		I	Inactivated by FDA		2026-10-16
excluded package	package	68828-129	68828-129-02	I	Inactivated by FDA		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 38 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68828-129-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68828-129-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68828-129-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68828-129-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68828-129-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68828-129-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68828-129-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68828-129-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68828-129-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68828-129-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68828-129-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68828-129-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68828-129-02	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68828-129-02	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68828-129-02	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68828-129-02	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68828-129-02	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68828-129-02	`bd6a592717d7…`	`303034d00443…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68828-129-02	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68828-129-02	2022-01-28	C162847	48780-1	9d75b9d1-00d2-f424-e053-dadaa90a57ce	Clear Blemish Treatment
68828-129-02	2020-06-22	C162847	48780-1	9d75b9d1-00d2-f424-e053-dadaa90a57ce	Clear Blemish Treatment
68828-129-02	2020-01-31	C162847	48780-1	9d75b9d1-00d2-f424-e053-dadaa90a57ce	Clear Blemish Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68828-129-01	Clear Blemish TreatmentJafra	15 mL in 1 TUBE	GEL	15		4
68828-129-02	Clear Blemish TreatmentJafra	1 in 1 BOX	GEL	1		4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
AZADIRACHTA INDICA BARK	INACTIVE INGREDIENT	G580B439YI	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	71DD5V995L	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
CLARY SAGE OIL	INACTIVE INGREDIENT	87L0D4U3M0	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
CLOVE LEAF OIL	INACTIVE INGREDIENT	VCA5491KVF	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
DENATONIUM BENZOATE	INACTIVE INGREDIENT	4YK5Z54AT2	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
DIETHYLENE GLYCOL MONOETHYL ETHER	INACTIVE INGREDIENT	A1A1I8X02B	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
LAVENDER OIL	INACTIVE INGREDIENT	ZBP1YXW0H8	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
PANTHENOL	INACTIVE INGREDIENT	WV9CM0O67Z	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
PPG-5-CETETH-20	INACTIVE INGREDIENT	4AAN25P8P4	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
SACCHARIDE ISOMERATE	INACTIVE INGREDIENT	W8K377W98I	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	22ADO53M6F	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1
YEAST	INACTIVE INGREDIENT	3NY3SM6B8U	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68828-129	CLEAR BLEMISH TREATMENT JAFRA (SALICYLIC ACID) GEL [JAFRA COSMETICS INTERNATIONAL]	4	Legacy NDC, 2 package rows	20200623_8fa82d96-d558-420b-b35d-6450f0148339.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
346298	salicylic acid 2 % Topical Gel	PSN	8fa82d96-d558-420b-b35d-6450f0148339	4
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	8fa82d96-d558-420b-b35d-6450f0148339	4
346298	salicylic acid 2 % Topical Gel	SY	8fa82d96-d558-420b-b35d-6450f0148339	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68828-129-01	68828012901	15 mL in 1 TUBE	15 ml					Historical
68828-129-02	68828012902	1 TUBE in 1 BOX (68828-129-02) > 15 mL in 1 TUBE (68828-129-01)	1 tube	2012-06-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Clear Blemish Treatment	JAFRA COSMETICS INTERNATIONAL \| Jafra Manufacturing, S.A. de C.V.	2020-06-22	HUMAN OTC DRUG LABEL	4